Lexette — Class II drug recall D-0387-2022
Ongoing recall by Mayne Pharma Inc, reported 2022-01-26, distributed nationwide. CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
| Recall number | D-0387-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mayne Pharma Inc, Greenville, NC, United States |
| Recall initiated | 2022-01-14 |
| Classified | 2022-01-19 |
| Reported by FDA | 2022-01-26 |
| Distributed | Nationwide (US) |
| Quantity | 17,113 canisters |
| Reason classes | cgmp |
| NDC | 51862-0604-50 |
| Lot numbers | 32451, 32532, 32552, 32701, 32733, 32855, 32872 |
| Expiration dates | 2022-03, 2022-04, 2022-05, 2022-10, 2023-02, 2023-03 |
Product
Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50
Reason for recall
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0387-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.